344 related articles for article (PubMed ID: 33141839)
1. Technical advance: The use of tree shrews as a model of pulmonary fibrosis.
Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB
PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839
[TBL] [Abstract][Full Text] [Related]
2. A novel tree shrew model of pulmonary fibrosis.
Che P; Wang M; Larson-Casey JL; Hu RH; Cheng Y; El Hamdaoui M; Zhao XK; Grytz R; Brent Carter A; Ding Q
Lab Invest; 2021 Jan; 101(1):116-124. PubMed ID: 32773774
[TBL] [Abstract][Full Text] [Related]
3. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
4. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
Front Immunol; 2021; 12():645548. PubMed ID: 34867934
[TBL] [Abstract][Full Text] [Related]
5. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C
Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686
[TBL] [Abstract][Full Text] [Related]
6. Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk.
Zeng C; Wang Q; Liu X; Wang K; Wang C; Ju X; Wang T; Zhou Q; Fu X; Yu J; Wang Y
Int J Nanomedicine; 2024; 19():1827-1842. PubMed ID: 38414524
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.
Kurowska-Stolarska M; Hasoo MK; Welsh DJ; Stewart L; McIntyre D; Morton BE; Johnstone S; Miller AM; Asquith DL; Millar NL; Millar AB; Feghali-Bostwick CA; Hirani N; Crick PJ; Wang Y; Griffiths WJ; McInnes IB; McSharry C
J Allergy Clin Immunol; 2017 Jun; 139(6):1946-1956. PubMed ID: 27746237
[TBL] [Abstract][Full Text] [Related]
8. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
[TBL] [Abstract][Full Text] [Related]
9. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL
Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
11. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
14. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
Tzouvelekis A; Yu G; Lino Cardenas CL; Herazo-Maya JD; Wang R; Woolard T; Zhang Y; Sakamoto K; Lee H; Yi JS; DeIuliis G; Xylourgidis N; Ahangari F; Lee PJ; Aidinis V; Herzog EL; Homer R; Bennett AM; Kaminski N
Am J Respir Crit Care Med; 2017 Feb; 195(4):500-514. PubMed ID: 27736153
[TBL] [Abstract][Full Text] [Related]
15. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR
Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972
[TBL] [Abstract][Full Text] [Related]
16. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.
Joshi S; Singh AR; Wong SS; Zulcic M; Jiang M; Pardo A; Selman M; Hagood JS; Durden DL
PLoS One; 2017; 12(8):e0182851. PubMed ID: 28817691
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis.
Larson-Casey JL; Saleem K; Surolia R; Pandey J; Mack M; Antony VB; Bodduluri S; Bhatt SP; Duncan SR; Carter AB
J Immunol; 2023 Dec; 211(11):1714-1724. PubMed ID: 37782053
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production.
He J; Du Y; Li G; Xiao P; Sun X; Song W; Lai L; Xia M; Zhang J; Wang Q
Front Immunol; 2021; 12():760138. PubMed ID: 35069531
[TBL] [Abstract][Full Text] [Related]
19. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
